Giovanni Bertalot

15PUBLICATIONS
124CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targetsCancer cell biologyBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 10, 2026
Glycolipid-lectin driven endocytosis as a therapeutic vulnerability in breast cancer.

|Feb 27, 2026
IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal Cancer.

Ottavia De Simoni, Melania Scarpa, Francesco Cavallin

|Oct 01, 2025
A histone-centric multi-omics study shows that increased H3K4 methylation sustains triple-negative breast cancer phenotypes.

Roberta Noberini, Giulia Robusti, Alessandro Vai

|Aug 27, 2025
Single-Cell mRNA Analysis for the Identification of Molecular Pathways of IRF1 in HER2+ Breast Cancer.

Laura Vilardo, Paride Pelucchi, Antonia Brindisi

|Aug 19, 2025
Drosophila and human cell studies reveal a conserved role for CEBPZ, NOC2L and NOC3L in rRNA processing and tumorigenesis.

Guglielmo Rambaldelli, Valeria Manara, Andrea Vutera Cuda

|Jan 27, 2025
From Flies to Humans: A Conserved Role of CEBPZ, NOC2L, and NOC3L in rRNA Processing and Tumorigenesis.

Guglielmo Rambaldelli, Valeria Manara, Andrea Vutera Cuda

Pageof 3

Frequent Collaborators

3 joint publications

Mattia Barbareschi

3 joint publications

Stefano Freddi

2 joint publications

Pier Paolo Di Fiore

2 joint publications

Ettore Mosca